---

---

publishing date : 2022 - 01 - 31    tags : Treatment   

save search

---

BrainsWay Announces Final Local Coverage Determination Issued by Regional Medicare Administrative Contractor Palmetto GBA Providing Coverage of Deep TMS™ for the Treatment of OCD
Published: 2022-01-31 (Crawled : 23:00) - globenewswire.com
BWAY | $4.89 2.95% 2.86% 28K |

Health Technology

| -32.96% | O: 6.42% H: 3.18% C: 2.79%
treatment ces contract

---

New York Mortgage Trust Announces Tax Treatment of 2021 Dividend Distributions
Published: 2022-01-31 (Crawled : 23:00) - globenewswire.com
NYMT | $7.205 2.05% 2.01% 590K |

Finance

| 88.27% | O: 0.53% H: 0.4% C: -1.06%
treatment distribution trust tga

---

Reata Pharmaceuticals Initiates Rolling Submission of New Drug Application with U.S. FDA for Omaveloxolone for the Treatment of Patients with Friedreich’s Ataxia
Published: 2022-01-31 (Crawled : 15:30) - biospace.com/
RETA | $172.36 0.02% 0.03% 0 |

Health Technology

| 592.21% | O: 1.0% H: 13.68% C: 11.81%
new drug treatment fda als application drug one submission friedreich's ataxia friedreich’s ataxia

---

Xeris Biopharma Announces Recorlev® (levoketoconazole) Is Now Commercially Available for the Treatment of Endogenous Hypercortisolemia in Adult Patients With Cushing’s Syndrome
Published: 2022-01-31 (Crawled : 15:30) - biospace.com/
XERS | $1.78 0.0% 1.3M |

Health Technology

| -14.01% | O: -4.35% H: 9.6% C: 6.57%
recorlev treatment biopharma syndros

---

FDA Approves Prophylactic Treatment with VONVENDI® [von Willebrand Factor (Recombinant)] for Adult Patients Living with Severe Type 3 von Willebrand Disease (VWD)
Published: 2022-01-31 (Crawled : 15:00) - biospace.com/
TAK | News | $13.38 0.15% 0.9% 1.7M |

Health Technology

| -7.22% | O: -0.14% H: 0.0% C: 0.0%
vonvendi treatment fda disease

---

SYNAPS Dx DISCERN Provides First-to-Market Definitive Diagnostic Test for Alzheimer’s Disease, Supports Payer Treatment Decisions, Releases Paper Authored by Advisory Council
Published: 2022-01-31 (Crawled : 15:00) - biospace.com/
NMTC | $1.13 -0.88% -0.88% 52K |

Real Estate and Rental and Leas...

| -41.54% | O: 0.0% H: 0.0% C: 0.0%
diagnostic alzheimer treatment disease test alzheimer’s alzheimer's disease alzheimer's

---

Viridian Therapeutics Announces FDA Clearance of Investigational New Drug Application to Initiate Clinical Development of VRDN-002, a Next Generation IGF-1R Antibody for the Treatment of Thyroid Eye Disease
Published: 2022-01-31 (Crawled : 15:00) - biospace.com/
VRDN | $14.23 -0.49% -0.49% 540K |

Health Care and Social Assistan...

| -21.99% | O: 0.55% H: 10.04% C: 9.06%
vrdn-002 new drug treatment fda clearance eye application eye disease drug therapeutics disease fda clearance antibody

---

Veru Announces FDA Grant of Fast Track Designation for Sabizabulin for the Treatment of Hospitalized COVID-19 Patients at High Risk for Acute Respiratory Distress Syndrome
Published: 2022-01-31 (Crawled : 14:30) - biospace.com/
VERU | $1.27 0.0% 2.6M |

Health Technology

| -73.21% | O: 1.69% H: 8.74% C: 7.88%
covid-19 fast track designation treatment fda risk fast track respiratory covid grant syndros sabizabulin designation

---

Apollo Commercial Real Estate Finance, Inc. Announces 2021 Dividend Income Tax Treatment
Published: 2022-01-31 (Crawled : 14:00) - globenewswire.com
ARI | $11.01 2.13% 0.0% 540K |

Finance

| -18.89% | O: -0.6% H: 3.48% C: 3.33%
treatment state commercialization

---

Cognitive Treatment for Anxious Depression
Published: 2022-01-31 (Crawled : 12:00) - brainsway.com
BWAY | $4.89 2.95% 2.86% 28K |

Health Technology

| -32.96% | O: 6.42% H: 3.18% C: 2.79%
treatment depression

---

Gainers vs Losers

77%

23%

Top 10 Gainers

MTTR | News M | $4.6 164.37% 62.17% 28M |

AGBA | $2.94 135.2% 57.48% 66M |

Finance

EDBL | News | $6.46 71.81% 41.8% 2M |

MTC | $2.25 44.23% 30.67% 6M |

Technology Services

OPRT | News | $3.175 41.11% 29.13% 12M |

Finance

SHIM | $3.05 35.56% 26.23% 870K |

HKIT | $1.345 31.86% 380K |

Technology Services

ABVC | $1.36 30.77% 23.53% 7.4M |

Wholesale Trade

OST | $0.512 28.0% 21.88% 290K |

POET | $1.59 27.2% 21.38% 4.2M |

Manufacturing

---

Your saved searches

---